Literature DB >> 25152343

Botulinum toxin for axillary hyperhidrosis.

Ada Regina Trindade de Almeida1, Suelen Montagner2.   

Abstract

Botulinum toxin is a safe and effective treatment option for axillary hyperhidrosis. Although its pathophysiology is not clear and somewhat controversial, the beneficial effect of neuromodulators in inhibiting localized sweating temporarily is well known. Before the procedure, correct identification of the affected area is mandatory to avoid wastage of drug and neglect of target areas, and to enhance efficacy, as the hyperhidrotic location may not match the hairy axillary region. Utilization of this medication, such as dilution and injection techniques, depends on medical experience and may have some variations, including methods to make the procedure as painless as possible.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axillary hyperhidrosis; Botox; Botulinum toxin; Excessive underarm sweating; Neuromodulators

Mesh:

Substances:

Year:  2014        PMID: 25152343     DOI: 10.1016/j.det.2014.06.013

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  6 in total

1.  Large eccrine angiomatous hamartoma: a novel clinical presentation of disease.

Authors:  Uffe Nygaard; Søren Dalager; Eva Spaun; Lene Hedelund
Journal:  J Dermatol Case Rep       Date:  2015-09-30

Review 2.  Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.

Authors:  Marius Nicolae Popescu; Cristina Beiu; Mădălina Gabriela Iliescu; Mara Mădălina Mihai; Liliana Gabriela Popa; Ana Maria Alexandra Stănescu; Mihai Berteanu
Journal:  Medicina (Kaunas)       Date:  2022-06-16       Impact factor: 2.948

3.  A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.

Authors:  Dee Anna Glaser; David M Pariser; Adelaide A Hebert; Ian Landells; Chris Somogyi; Emily Weng; Mitchell F Brin; Frederick Beddingfield
Journal:  Pediatr Dermatol       Date:  2015-06-08       Impact factor: 1.588

4.  Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production.

Authors:  Rungsima Wanitphakdeedecha; Watsachon Kantaviro; Panittra Suphatsathienkul; Ploypailin Tantrapornpong; Chadakan Yan; Chalermkwan Apinumtham; Yuttana Srinoulprasert
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-22

5.  New trends in botulinum toxin use in dermatology.

Authors:  Stefania Guida; Francesca Farnetani; Steven P Nisticò; Caterina Giorgio Mariarosaria; Graziella Babino; Giovanni Pellacani; Elisabetta Fulgione
Journal:  Dermatol Pract Concept       Date:  2018-10-31

6.  Brain functional changes in patients with botulism after illegal cosmetic injections of botulinum toxin: A resting-state fMRI study.

Authors:  Ge-Fei Li; Shiyu Ban; Mengxing Wang; Jilei Zhang; Haifeng Lu; Yan-Hui Shi; Xin-Wei He; Yi-Lan Wu; Peng Peng; Yi-Sheng Liu; Mei-Ting Zhuang; Rong Zhao; Xiao-Lei Shen; Qiang Li; Jian-Ren Liu; Xiaoxia Du
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.